Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7262
+0.0110 (1.54%)
Aug 14, 2025, 2:15 PM - Market open

Nautilus Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
92211374225643-
Upgrade
Market Cap Growth
-68.80%-43.55%66.44%-65.09%--
Upgrade
Enterprise Value
-29102226-4299-
Upgrade
Last Close Price
0.721.682.991.805.1810.85
Upgrade
PB Ratio
0.501.011.410.711.77-
Upgrade
P/TBV Ratio
0.501.011.410.711.77-
Upgrade
Debt / Equity Ratio
0.160.150.130.100.080.06
Upgrade
Quick Ratio
18.1717.0219.0127.1659.4925.43
Upgrade
Current Ratio
18.5217.4019.3927.5760.0925.73
Upgrade
Return on Equity (ROE)
-31.55%-29.86%-21.95%-17.07%-22.75%-32.29%
Upgrade
Return on Assets (ROA)
-19.30%-18.57%-14.52%-10.62%-13.06%-19.00%
Upgrade
Return on Capital (ROIC)
-19.65%-18.89%-14.75%-10.76%-13.23%-19.38%
Upgrade
Earnings Yield
-72.51%-33.55%-17.04%-25.80%-7.82%-
Upgrade
FCF Yield
-62.98%-29.40%-14.49%-21.44%-6.45%-
Upgrade
Buyback Yield / Dilution
-0.53%-0.41%-0.27%-47.51%-190.36%-379.48%
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q